A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
Clinical trial NCT00476996 · TERMINATED
Trial details
- NCT number
- NCT00476996
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-15
- Primary completion
- 2010-01-21
- Enrollment
- 836
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.